Skip to main content

BIO-TECHNE Corp net income

  • TECH · Nasdaq
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$72.80−0.05%Close 13 Nov 2026

BIO-TECHNE Corp's net income was $182 million for fiscal year 2026 (the twelve months to 30 Jun 2026), up 148% from fiscal 2025.

In the first quarter of fiscal 2027 (the three months to 30 Sep 2026) it was $28.3 million, down 25.9% from a year earlier.

Over the four quarters to 30 Sep 2026, net income was $172 million.

From BIO-TECHNE Corp's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 6 Nov 2026.

Fiscal 2026
$182M
+148%
Q1 FY2027
$28.3M
−25.9% on a year
Growth over 9 years
+10.2%
a year, FY 2017–FY 2026

Net income by fiscal year

$76.1MFY 2017$126MFY 2018+65.8%$96.1MFY 2019−23.8%$229MFY 2020+139%$140MFY 2021−38.8%$272MFY 2022+93.8%$285MFY 2023+4.9%$168MFY 2024−41.1%$73.4MFY 2025−56.4%$182MFY 2026+148%

Change on the year before, under each year. From FY 2017 to FY 2026, BIO-TECHNE Corp's net income went from $76.1 million to $182 million, a compound annual change of +10.2%; the highest was $285 million in FY 2023.

BIO-TECHNE Corp net income, fiscal years
PeriodFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Net income$76.1M$126M$96.1M$229M$140M$272M$285M$168M$73.4M$182M
Period end30 Jun 201730 Jun 201830 Jun 201930 Jun 202030 Jun 202130 Jun 202230 Jun 202330 Jun 202430 Jun 202530 Jun 2026

Net income by quarter

The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.

BIO-TECHNE Corp net income, fiscal quarters
PeriodQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Net income$34.9M$22.6M−$17.7M$38.2M$38.0M$51.0M$54.6M$28.3M
Period end31 Dec 202431 Mar 202530 Jun 202530 Sep 202531 Dec 202531 Mar 202630 Jun 202630 Sep 2026

How net income is measured

Net income is the profit left after every expense, interest and income tax, attributable to the company's shareholders. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.

BIO-TECHNE Corp's other figures

Net income of comparable companies

Everything on TECH, in the terminal.

Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.